Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.9 USD | -4.52% | -2.56% | -36.45% |
03-25 | Esperion Shares Continue Rise After Friday's FDA Approval for Nexlizet, Nexletol | DJ |
03-25 | Sector Update: Health Care Stocks Steady Premarket Monday | MT |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapies
100.0
%
| 75 | 100.0 % | 116 | 100.0 % | +54.14% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 75 | 100.0 % | 116 | 100.0 % | +54.14% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sheldon Koenig
CEO | Chief Executive Officer | 58 | 20-12-14 |
Director of Finance/CFO | 38 | 19-12-31 | |
JoAnne Foody
CTO | Chief Tech/Sci/R&D Officer | 59 | 21-06-27 |
Glenn Brame
CTO | Chief Tech/Sci/R&D Officer | 67 | 23-01-31 |
Alexis Callahan
IRC | Investor Relations Contact | - | - |
Betty Jean
PRN | Corporate Officer/Principal | - | 21-01-31 |
Benjamin Looker
LAW | General Counsel | 42 | 21-12-31 |
Corporate Officer/Principal | - | - | |
Eric Warren
PRN | Corporate Officer/Principal | 76 | 20-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 52 | 22-04-27 | |
J. Carroll
CHM | Chairman | 74 | 22-05-31 |
Alan Fuhrman
BRD | Director/Board Member | 67 | 20-03-15 |
Antonio M. Gotto
BRD | Director/Board Member | 88 | 14-01-13 |
Nicole Vitullo
BRD | Director/Board Member | 66 | 08-03-31 |
Jay Shepard
BRD | Director/Board Member | 66 | 18-05-28 |
Seth Fischer
BRD | Director/Board Member | 68 | 21-10-27 |
Tracy M. Woody
BRD | Director/Board Member | 54 | 19-04-30 |
Sheldon Koenig
CEO | Chief Executive Officer | 58 | 20-12-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 191,394,765 | 188,547,683 ( 98.51 %) | 1,994,198 ( 1.042 %) | 98.51 % |
Company contact information
Esperion Therapeutics, Inc.
3891 Ranchero Drive Suite 150
48108, Ann Arbor
+734 887 3903
http://www.esperion.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.45% | 360M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- ESPR Stock
- Company Esperion Therapeutics, Inc.